SFA
ATRS

Sequoia Financial Advisors’s Antares Pharma, Inc. ATRS Stock Holding History

Sequoia Financial Advisors’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-100,950
Closed -$238K – 412
2020
Q1 		$238K Buy
+100,950
New +$343K 0.02% 307

Other funds holding ATRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
CWM
Centric Wealth Management Chicago, Illinois $501M AUM 15.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Sequoia Financial Advisors's ATRS Position: Q2 2020 in Review

Sequoia Financial Advisors sold out of Antares Pharma, Inc. (ATRS) in Q2 2020, closing a stake of 100,950 shares — an estimated $238K sold.

Sequoia Financial Advisors first reported a position in ATRS in Q1 2020 and held it in 1 quarter. The position peaked at $238K in Q1 2020. 159 funds tracked by Wall St. Rank hold ATRS as of Q2 2020.

  • Sequoia Financial Advisors reported no remaining Antares Pharma, Inc. position as of Q2 2020 after selling out during the quarter.
  • Sequoia Financial Advisors sold 100,950 Antares Pharma, Inc. shares in Q2 2020, an estimated $238K.
  • Sequoia Financial Advisors first reported a position in Antares Pharma, Inc. in Q1 2020 and held it in 1 quarter.
  • Sequoia Financial Advisors's Antares Pharma, Inc. position peaked at $238K in Q1 2020.
  • 159 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2020.

Based on Sequoia Financial Advisors's 13F filing for Q2 2020, filed 11 Aug 2020.